Mr. R Sankaraiah

Executive Director – Finance

Mr. R. Sankaraiah, B.Sc., CA, serves as an Executive Director of Finance at Jubilant Life Sciences Limited and Jubilant Biosys Limited. Mr. Sankaraiah is responsible for the financial planning, treasury operations, accounting, taxation, legal, secretarial, investor relations, management assurance and information technology functions of Jubilant and its subsidiaries. He serves as Group Finance Director of the Jubilant Bhartia Group Companies. He joined Jubilant on September 9, 2002 and has experience of 29 years. Prior to Jubilant, he was with SRF Limited, New Delhi and held various positions spanning more than 16 years. He served as General Manager of Finance at SRF Ltd. He has been a Director of Cadista Pharmaceuticals, Inc. since July 31, 2013. He serves as a Director of Axis Holding Pvt Ltd. Mr. Sankaraiah serves as a Director of Jubilant Biosys Limited. He has been a Director of Cadista Holdings Inc. since July 31, 2013 and previously served the same position from June 2005 to May 4, 2012. He served as Director of Jubilant Industries Limited until November 26, 2010. He served as Director of Cadista Pharmaceuticals, Inc. from June 2005 to May 4, 2012. He is a Member of the Chief Financial Officer working group, formed by the Ministry of Corporate Affairs of the Government of India to look into issues on convergence of International Generally Accepted Accounting Principles and International Financial Reporting Standards and a member of the collation on international taxation in India. Mr. Sankaraiah is a fellow member of the Institute of Chartered Accountants of India and holds B.Sc. degree.